NCT03879980 is a NA clinical trial of Bilateral QL block in Postoperative Pain, sponsored by Indonesia University.

Who is sponsoring NCT03879980?

NCT03879980 is sponsored by Indonesia University.

What drugs are being tested in NCT03879980?

Interventions in NCT03879980: Bilateral QL block, Non-QL block.

What condition does NCT03879980 study?

NCT03879980 studies Postoperative Pain.

Is NCT03879980 still recruiting?

NCT03879980 is currently completed. Last updated 10 July 2019.

Last reviewed 2019-07-10 · How we verify

NCT03879980

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Quadratus Lumborum Block on Perioperative Analgesia and Inflammatory Responses in Laparoscopic Nephrectomy

Completed NA Last updated 10 July 2019

What this trial tests

NA trial testing Bilateral QL block in Postoperative Pain in 44 participants. Completed in 17 June 2019.

Timeline

18 March 2019

Primary endpoint
13 May 2019

17 June 2019

Quick facts

Lead sponsor	Indonesia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	44
Start date	18 March 2019
Primary completion	13 May 2019
Estimated completion	17 June 2019
Sites	1 location across Indonesia

Drugs / interventions tested

Bilateral QL block — full drug profile →
Non-QL block — full drug profile →

Conditions studied

Postoperative Pain — all drugs for Postoperative Pain →

Sponsor

Indonesia University

Who can join

Adults 18 to 65, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Quadratus lumborum (QL) block can reduce intraoperative opioid consumption, decrease inflammation responses of IL-6, and reduce acute pain intensity in comparison with non-receiving QL block as the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Bilateral QL block

Trials testing the same drug.

NCT06721039 — Comparison of Ultrasound-Guided Quadratus Lumborum Plane Block Versus Intraperitoneal and Periportal Bupivacaine Infiltr · NA · completed

Other Indonesia University trials

Trials by the same sponsor.

NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03879980 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indonesia University
Last refreshed: 10 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03879980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing